Bonus BioGroup (OTC:BBIXF) Stock, Quote.Headers.trade-ideas

Bonus BioGroup Ltd is a biotechnology company. It generates viable tissue-regenerating bone grafts. The company treats skeletal disorders such as bone- and cartilage-related arthritis and various types of bone and joint trauma. It is in the field of tissue engineering, human adipose tissue-derived cells and live bone transplantation.

BONUS BIOGROUP LTD by Bonus Biogroup Ltd.

Bonus BioGroup Ltd

Moody&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mco#NYSE">MCO</a>) has been on a downward spiral lately with significant selling pressure. After declining 5.1% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.
<h2>Guide to Identifying Oversold Stocks</h2>
We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.
RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.
Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock&#39;s price is reaching a point of reversal.
So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefitting from the inevitable rebound.
However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision.
<h2>Why MCO Could Bounce Back Before Long</h2>
The heavy selling of MCO shares appears to be in the process of exhausting itself, as indicated by its RSI reading of 29.69. So, the trend for the stock could reverse soon for reaching the old equilibrium of supply and demand.
<img alt="3-month RSI Chart for MCO" class="chart" src="https://staticx-tuner.zacks.com/images/articles/charts/yseop/544/MCO_RCI14.jpeg" style="height:auto; width:100%" title="" />
The RSI value is not the only factor that indicates a potential turnaround for the stock in the near term. On the fundamental side, there has been strong agreement among the sell-side analysts covering the stock in raising earnings estimates for the current year. Over the last 30 days, the consensus EPS estimate for MCO has increased 0.9%. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term.
Moreover, MCO currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock&#39;s potential turnaround in the near term.
<a href="https://www.zacks.com/stock/news/2347416/down-5-13-in-4-weeks-here-s-why-you-should-you-buy-the-dip-in-moody-s-mco?cid=CS-BENZ-FT-tale_of_the_tape|rsi-2347416">To read this article on Zacks.com click here.</a>

Earnings

Large Cap

News

Technicals

Markets

Analyst Ratings

Trading Ideas

Down -5.13% in 4 Weeks, Here's Why You Should You Buy the Dip in Moody's

Rio Tinto plc ADR Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) shares are trading lower by 4.2% to $66.65 Tuesday afternoon. Shares of copper and iron ore companies are trading lower amid China <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41227136/chinese-stocks-plunge-as-stimulus-hopes-fade-hong-kong-posts-worst-daily-decline-si">stimulus uncertainty</a>.
What Happened: Rio Tinto shares fell today in response to a sharp selloff in Chinese markets, with the Hang Seng Index plunging more than 9%. 
The drop, the index's worst since the 2008 financial crisis, was driven by mounting investor disappointment over the lack of aggressive economic stimulus from Beijing, sparking fears of slowing demand for key commodities like iron ore, copper and aluminum—major products in Rio Tinto&#8217;s portfolio.
Rio Tinto&#8217;s business is closely tied to the health of the Chinese economy, which accounts for a significant portion of global demand for industrial metals. As one of the world's largest consumers of raw materials, China's economic policies and growth trajectory have a direct impact on the mining giant's revenues.
Read Also: <a href="https://www.benzinga.com/news/earnings/24/10/41236355/stocks-rally-as-oil-prices-tumble-tech-chipmakers-lead-as-traders-focus-on-ai-winners-before-earnin">Stocks Rally As Oil Prices Tumble; Tech, Chipmakers Lead As Traders Focus On AI Winners Before Earnings Season: What&#8217;s Driving Markets Tuesday?</a>
What Else: For Rio Tinto, the market reaction reflects growing concerns about the demand outlook for industrial commodities, particularly iron ore, which is used primarily in steel production—a key component of China's infrastructure and construction sectors. Without strong stimulus measures, particularly in the form of new infrastructure projects or housing construction, analysts fear that China's demand for iron ore could stagnate or even decline. This would be a major headwind for Rio Tinto, which derives a significant portion of its revenue from iron ore production in Australia, one of the company&#8217;s core businesses.
Copper, a key material in construction, electronics and renewable energy projects, has been a focal point for Rio Tinto's growth strategy as it positions itself to benefit from the global energy transition. However, if China's economic slowdown continues, demand for copper and aluminum could also weaken, further weighing on Rio Tinto's outlook.
Rio Tinto has been benefiting from strong commodity prices over the past few years, driven by China's previous stimulus efforts and post-pandemic recovery. But the current lack of significant fiscal support from Beijing raises concerns that the mining giant may face softer demand, particularly if economic growth in China continues to fall short of expectations. 
With China's property sector still facing challenges and infrastructure investment lagging, the absence of a more aggressive stimulus package could signal a slower rebound in key industries that drive commodity consumption.
<a href="https://www.benzinga.com/markets/cannabis/24/10/41233018/exclusive-ross-gerber-sees-tsunami-of-money-pouring-into-cannabis-companies-upon-federal-legaliz">EXCLUSIVE: Ross Gerber Sees &#8216;Tsunami Of Money&#8217; Pouring Into Cannabis Companies Upon Federal Legalization, Says Cannabis Is One Of &#8216;Biggest&#8217; Opportunities Beyond AI</a>
<h2 class="wp-block-heading">Is RIO A Good Stock To Buy?</h2>
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages &#8211; like <a href="https://www.benzinga.com/quote/RIO">Rio Tinto</a>&#8216;s page for example &#8211; there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
These are known as capital allocation programs. Rio Tinto does pay a dividend, which yields 7.77% per year as of the closing price on Oct. 8, 2024. Feel free to search Benzinga's <a href="https://www.benzinga.com/calendars/dividends">dividend calendar</a> for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
For example, if you're looking to earn an annualized return of 14.18%, you'll need to buy a share of Ellington Residential by the Oct. 31, 2024. Once done, you can expect to receive a nominal payout of $0.08 on Nov. 25, 2024.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on <a href="https://www.benzinga.com/quote/RIO">Rio Tinto</a> will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, RIO has a 52-week high of $75.09 and a 52-week low of $59.35.

Why Rio Tinto Stock Is Trading Lower Tuesday

RBC Capital analyst Shagun Singh maintains Teleflex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFX#NYSE">TFX</a>) with a Outperform and raises the price target from $260 to $275.

Price Target

RBC Capital Maintains Outperform on Teleflex, Raises Price Target to $275

<a href="https://www.benzinga.com/events/cannabis-conference/livestream/">https://www.benzinga.com/events/cannabis-conference/livestream/</a>

Cannabis

Events

Exclusives

MSOS

iAnthus CEO Richie Proud Says Brands Emotionally Connect With Consumers But Not Everybody Is A Great Storyteller; Says To Think About What Is The Role That A Product Plays In A Consumer's Life, Think About Balancing Consumer Retention And New Consumer Acquisition

RBC Capital analyst Shagun Singh maintains Penumbra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>) with a Outperform and raises the price target from $205 to $222.

RBC Capital Maintains Outperform on Penumbra, Raises Price Target to $222

Joby Aviation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/joby#NYSE">JOBY</a>) technology has been again validated. The latest news is a follow-on investment from Toyota Motor (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tm#NYSE">TM</a>), one of the company&#39;s earliest investors and a long-time proponent of personal air capability. The new deal will more than double Toyota&#39;s investment in Joby, bringing the total to nearly $900 million, with funds distributed over the next two years. Toyota is a critical partner for Joby. Not only does it provide funding, but also powertrain and actuation components. Its engineers are working alongside Joby&#39;s to make commercialized personal flight a reality.
The new funding aims to aid Joby in its certification process and production ramp, which are progressing nicely. Joby is roughly a third of the way through the fourth of five stages of U.S. certification, has delivered its first vehicles to the U.S. Air Force, and is making inroads into other markets, including the UAE. Terms of the new deal include a manufacturing alliance to bolster the already blossoming production capability. While there are still hurdles to cross, the outlook is bright and points to the commencement of commercial operations in 2025. Regarding the UAE, Joby has begun the certification process for commercial air taxi services.
And Toyota is not Joby&#39;s only major investor. The company also has support from Delta Airlines, which has a vision for city-to-airport hub transportation services to complement its current operations. The initial investment is worth $60 million and may be raised to as much as $200 million, not including ancillary investments from firms such as Virgin Atlantic. Virgin Atlantic, 49% owned by Delta, is reportedly working on a deal to bring premium air taxi services to applicable markets.&nbsp;
<h2>Analysts Sentiment Favors Joby Shareholders</h2>
Analyst coverage of Joby Aviation remains light in number but is noteworthy because of sentiment and the price targets. The latest updates are reaffirmed ratings from H.C. Wainright and Cantor Fitzgerald, which peg the stock at Buy/Overweight with a price target more than 50% above the recent action, which includes the recent 25% share price pop.&nbsp;
The notes suggest that Joby is progressing with milestones and deliveries, is on track to produce one vehicle monthly by the end of the year, and has several opportunities for commercialization likely to bear fruit within the next 12 months. Those include commercial operations in the U.S., increased demand from the U.S. government, and air taxi services in the Middle East. Among the opportunities for investors is the company&#39;s vertically integrated production capability, which set it up to produce its components and maximize the software to operate them.&nbsp;&nbsp;
<h2>Insider Sales of Joby Stock Are No Problem for Shareholders</h2>
The insiders have been selling Joby on a quarter-to-quarter basis for the last two years but present no problem for the market. Insider sales align with activity resulting from share-based compensation and amount to less than 0.2% of the market cap with the stock at $6. Insiders and major shareholders still own more than 33% of the stock, and sales are offset by institutional activity. The institutions have been loading up on Joby shares in 2024, raising their holdings to roughly 45% of the shares with inflows more than doubling outflows over the past 12 months.&nbsp;
<h2>Short-Covering Adds Lift to Joby Aviation Stock Price Action&nbsp;</h2>
Joby&#39;s stock price rocketed higher following the Toyota news, but more was driving the stock than the news. The market for Joby was more than 15% short as of the mid-September report, providing ample fuel for the squeeze. With commercial operations still several quarters away, it is likely that short interest will remain high and may cap gains until additional news is released. The critical target for resistance is near the $6.50 level, which may be reached soon. Assuming the market cannot cross that line and hold it, JOBY share price will likely remain range-bound near 2024&#39;s lows. However, a move above $7.50 would alter the technical outlook and raise the chances for a sustained rally for Q4 2024 into 2025.&nbsp;
<img alt="Joby Aviation JOBY stock chart" class="aligncenter" src="https://www.marketbeat.com/logos/articles/med_20241003074524_chart-joby-1032025.png" style="height:423px; width:917px" />
The article &quot;<a href="https://www.marketbeat.com/originals/joby-aviation-soars-with-toyota-investment-and-analyst-support/">Joby Aviation Soars With Toyota Investment and Analyst Support</a>&quot; first appeared on MarketBeat.

Mid Cap

Insider Trades

JOBY

Joby Aviation Soars With Toyota Investment and Analyst Support

Jamie Mendola Of Ayr Wellness Says We're Seeing Growth In Sophistication Of Question Consumers Are Asking

MariMed CEO Jon Levine Says We're Looking At The End User, One Of Those Things Is Precision Dose, Consistency; We've Done Research On Wholesale And Research Side To Reach And Educate Customers So Customers Will Feel Comfortable With Brand

RBC Capital analyst Shagun Singh maintains Medtronic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) with a Sector Perform and raises the price target from $92 to $98.

RBC Capital Maintains Sector Perform on Medtronic, Raises Price Target to $98

Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) has been riding the AI wave for some time, and its latest announcement sent <a href="https://www.benzinga.com/news/24/10/41231858/whats-going-on-with-super-micro-computer-stock">the stock soaring again</a>.
Shares jumped 15% after the company revealed it&#8217;s shipping over 100,000 GPUs per quarter, a figure that could translate into billions of dollars in potential revenue, with GPUs being the core hardware behind AI development and deployment.
But while the stock got a short-term boost, questions about its sustainability loom large. It soon receded and was down by about 7% by 1:30 PM ET.
<h2 class="wp-block-heading">AI Infrastructure Powers Stock Surge</h2>
Super Micro has been a major player in supplying AI infrastructure, and the latest GPU shipment announcement highlights its role in powering some of the biggest AI data centers. The company's new liquid cooling technology also caught Wall Street's attention, as it promises to reduce costs and optimize hardware for data centers that run constantly. 
But there's a wrinkle: Super Micro has been dealing with investigations, including a Department of Justice probe following short-seller allegations of accounting issues.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/downgrades/24/09/40739728/super-micro-down-60-since-joining-s-p-500-barclays-drops-bull-stance-on-customer-erosi">Super Micro Down 60% Since Joining S&amp;P 500, Barclays Drops Bull Stance On &#8216;Customer Erosion And Weak AI Server Margins&#8217;</a>
<h2 class="wp-block-heading">Headwinds Persist Despite Rally</h2>
Even with this impressive GPU announcement, Super Micro is battling broader headwinds. 
Despite the recent rally, the stock remains down over 50% since peaking in March, and technical indicators suggest the path ahead could be rocky.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="625" height="456" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08140856/Screenshot-2024-10-08-at-11.38.35-PM.png" alt="" class="wp-image-586264" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08140856/Screenshot-2024-10-08-at-11.38.35-PM.png 625w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08140856/Screenshot-2024-10-08-at-11.38.35-PM-300x219.png 300w" sizes="(max-width: 625px) 100vw, 625px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100824&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
Currently trading at $44.44, the stock is below both its 50-day and 200-day simple moving averages ($50.23 and $70.92, respectively), which are typically bearish signals.
Read Also: <a href="https://www.benzinga.com/news/24/10/41231858/whats-going-on-with-super-micro-computer-stock">What&#8217;s Going On With Super Micro Computer Stock?</a>
<h2 class="wp-block-heading">Bullish Signs, But Uncertainties Remain</h2>
Still, the stock price sits above its eight-day and 20-day SMAs, signaling near-term bullish potential.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="625" height="456" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08140912/Screenshot-2024-10-08-at-11.37.17-PM.png" alt="" class="wp-image-586265" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08140912/Screenshot-2024-10-08-at-11.37.17-PM.png 625w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08140912/Screenshot-2024-10-08-at-11.37.17-PM-300x219.png 300w" sizes="(max-width: 625px) 100vw, 625px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100824&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
The MACD, however, remains negative, and while the RSI at 47.36 isn't in overbought territory, it suggests that investor enthusiasm could face hurdles. 
The AI demand boom has propelled Super Micro, but with ongoing legal and financial uncertainties, the real question is whether this surge can last.
For now, it seems like investors are still very much along for the ride.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41213960/stocks-slip-as-oil-prices-surge-10-year-yields-cross-4-energy-sector-outperforms-whats-driving-m">Stocks Fall As Oil Prices Spike, 10-Year Yields Top 4%; Energy Sector Outperforms: What&#8217;s Driving Markets Monday?</a></li>
</ul>
Image: Shutterstock

Tech

SMCI

Super Micro Computer Stock Volatile On 100K GPU Shipments: Can AI Hype Keep It Up?

Marijuana companies would be "treated like normal businesses," if the oppressive restrictions of Section 280E of the Internal Revenue Code, which prevents cannabis businesses from deducting typical business expenses, go away. 
That's according to Darren Weiss, president of Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTCQX">VRNOF</a>), who joined three other industry experts at the <a href="https://www.benzinga.com/events/cannabis-conference/">Benzinga Cannabis Capital Conference</a> in Chicago on Tuesday for the panel, &#8220;Life After 280E, Different Companies, Different Scenarios: More Money For All?&#8221;
Without paying 280E taxes, companies such as Verano with active operations spanning 14 U.S. states, would have additional dollars to direct toward research and development efforts.
Having extra cash is an "opportunity to engage in more sort of hard science R&amp;D which is not been the bulwark of this industry," Weiss told the crowd at the Marriott Magnificent Mile. He added that single-state operators would also be able to do business successfully and "survive."
Laurie Holcomb, CEO of Gold Flora Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GRAM#OTC">GRAM</a>); Mackenzie Peterson, vice president of marketing at AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>) and Peter Sack, managing partner at Chicago Atlantic Real Estate Finance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REFI#NASDAQ">REFI</a>), also participated in the panel with Weiss. David Feuerstein, co-founder and partner at Feuerstein Kulick, moderated.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08135822/ccc-oct-24-banner__1_-17.gif" alt="" class="wp-image-586238" /></a></figure>
In the long run, having more money on their balance sheets without the complexity imposed by 280E would make cannabis businesses more attractive to potential investors, AdvisorShares' Peterson said. Operating like a normal business would make investors see a cannabis company as an opportunity.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41233018/exclusive-ross-gerber-sees-tsunami-of-money-pouring-into-cannabis-companies-upon-federal-legaliz">EXCLUSIVE: Ross Gerber Sees &#8216;Tsunami Of Money&#8217; Pouring Into Cannabis Companies Upon Federal Legalization, Says Cannabis Is One Of &#8216;Biggest&#8217; Opportunities Beyond AI</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h1 class="wp-block-heading">280E Going Away Is Paired With Rescheduling</h1>
"Companies will benefit just by having more money on their balance sheets that can go into a ton of different places," Peterson said referring to 280E going away, a milestone that will "be paired with rescheduling."
But, cannabis rescheduling — a topic widely discussed and addressed for years — is not plausible in 2024, according to Peterson, even though both of the presidential picks for the November elections seem to be at least pro-cannabis.
Chicago Atlantic's Sack, who manages a lending company to the cannabis industry and has deployed close to two billion dollars, called former President Donald Trump&#8216;s endorsement of rescheduling "a major milestone." Having the Republican candidate endorsing rescheduling changes the dynamic in the conversation from "if" to "when" it will happen, he added.
Sack said the policy change around cannabis alongside 280E going away would&nbsp;make companies like his "more willing to provide capital to the industry."
"I think it&#8217;s an incremental puzzle piece leading to what I think will be really transformational of uplifting," Sack continued.
Gold Flora's Holcomb agrees. Cannabis policy change would also help crack down on illicit sales, she explained, referring to the burning issue in California.
Having more money in the legal market and not being subject to the tax structure that includes local and state taxes in addition to 280E, would allow operators to offer pricing to consumers at the same price as illicit operators.
She added the price will change once California sees more legal stores open. "We only have about a thousand, we need three thousand, so it starts with that," Holcomb said.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41236050/californias-largest-cannabis-delivery-service-closes-down-lays-off-500-workers">California&#8217;s Largest Cannabis Delivery Service Closes Down, Lays Off 500 Workers</a></li>
</ul>
Photo: Benzinga Cannabis Conference 2024, &#8220;Life After 280E, Different Companies, Different Scenarios: More Money For All?&#8221;, Photo by Wendy Davis.

Regulations

Financing

Politics

GRAM

GRAMF

REFI

VRNOF

EXCLUSIVE: Weed Companies Will Be Treated Like Normal Businesses Once This Tax Provision Goes Away, Experts Say

How much a stock&#39;s price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and industries.
Another factor that can influence investors is FOMO, or the fear of missing out, especially with tech giants and popular consumer-facing stocks.
What if you&#39;d invested in Caterpillar (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cat#NYSE">CAT</a>) ten years ago? It may not have been easy to hold on to CAT for all that time, but if you did, how much would your investment be worth today?
<h2>Caterpillar&#39;s Business In-Depth</h2>
With that in mind, let&#39;s take a look at Caterpillar&#39;s main business drivers.
Caterpillar, known for its iconic yellow machines, is the largest global construction and mining equipment manufacturer. Given that it serves a gamut of sectors - infrastructure, construction, mining, oil &amp; gas and transportation, the company is considered a bellwether of the global economy.
Since 1925, Caterpillar&#39;s product portfolio has evolved and boasts 20 brands and generated revenues of $67 billion in 2023. It has more than 4 million products with an extensive dealer network of 156 dealers spanning 190 countries.
Caterpillar started using telematics in the 1990s and reached its target of 1 million connected assets in 2019. It currently has more than 1.5 million connected assets. The combination of innovation, and cutting-edge technology, coupled with the formidable reputation, set Caterpillar apart from its peers.
Caterpillar is the 41st largest company on the S&amp;P 500 Index, with a market capitalization of around $191 billion. It holds the fifth position in the Dow Jones Industrial Average, with a 6.13% weight. It is also a member of the S&amp;P 500 Dividend Aristocrat Index.
The Irving, TX-based company has six operating segments.
Machinery, Energy &amp; Transportation (ME&amp;T) (95.2% of total revenues in 2023) includes the Construction Industries segment, which manufactures machinery utilized in infrastructure, forestry and building construction.
The Resource Industries segment caters to customers using machinery in mining, quarry and aggregates, heavy construction, waste and material handling applications.
The Energy &amp; Transportation segment supports customers in oil and gas, power generation, marine, rail and industrial applications.
All Other Segments primarily comprise activities such as re-manufacturing CAT engines and components and re-manufacturing services for other companies and product management, development, manufacturing, marketing and product support.
Financial Products Segment (5.9% of total revenues in 2023) provides retail and wholesale financing alternatives for Caterpillar products.
&nbsp;
&nbsp;
<h2>Bottom Line</h2>
Anyone can invest, but building a successful investment portfolio requires research, patience, and a little bit of risk. So, if you had invested in Caterpillar ten years ago, you&#39;re likely feeling pretty good about your investment today.
According to our calculations, a $1000 investment made in October 2014 would be worth $4,205.39, or a gain of 320.54%, as of October 8, 2024, and this return excludes dividends but includes price increases.
In comparison, the S&amp;P 500 gained 194.35% and the price of gold went up 107.86% over the same time frame.
Going forward, analysts are expecting more upside for CAT.
Caterpillar&#39;s earnings have increased year over year for fourteen straight quarters aided by cost-saving and pricing actions. The Construction Industries segment will gain from the increased construction activities in the United States and globally. The mining sector will be bolstered by commodity demand driven by the energy transition trend, which will support the Resource Industries segment. Recovery in demand in China, boosted by the recent stimulus measures, will boost the need for Caterpillar&#39;s equipment. The Energy &amp; Transportation segment is well-positioned for growth, backed by strong demand across all applications. Its dividend yield and payout ratio are higher than its peers. A solid liquidity position and Caterpillar&#39;s investments in expanding services and digital initiatives will help deliver exceptional returns.
The stock is up 19.22% over the past four weeks, and no earnings estimate has gone lower in the past two months, compared to 3 higher, for fiscal 2024. The consensus estimate has moved up as well.
<a href="https://www.zacks.com/stock/news/2347283/if-you-invested-1000-in-caterpillar-a-decade-ago-this-is-how-much-it-d-be-worth-now?cid=CS-BENZ-FT-tale_of_the_tape|investing_$1000-2347283">To read this article on Zacks.com click here.</a>

Dividends

If You Invested $1000 in Caterpillar a Decade Ago, This is How Much It'd Be Worth Now

RBC Capital analyst Shagun Singh maintains Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) with a Outperform and raises the price target from $175 to $178.

RBC Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $178

Richtech Robotics's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RR#NYSE">RR</a>) short percent of float has fallen 12.44% since its last report. The company recently reported that it has 1.95 million shares sold short, which is 3.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Richtech Robotics Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728413123_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Richtech Robotics has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Richtech Robotics's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Richtech Robotics's peer group average for short interest as a percentage of float is 4.23%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Richtech Robotics?

NiSource's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NI#NYSE">NI</a>) short percent of float has fallen 43.21% since its last report. The company recently reported that it has 8.22 million shares sold short, which is 2.09% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.04 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>NiSource Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728413118_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for NiSource has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing NiSource's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, NiSource's peer group average for short interest as a percentage of float is 2.81%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(NI) - Analyzing NiSource's Short Interest

Royalty Pharma's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPRX#NYSE">RPRX</a>) short percent of float has fallen 3.24% since its last report. The company recently reported that it has 14.19 million shares sold short, which is 3.29% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.05 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Royalty Pharma Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728413113_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Royalty Pharma has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Royalty Pharma's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Royalty Pharma's peer group average for short interest as a percentage of float is 4.51%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

RPRX

Peering Into Royalty Pharma's Recent Short Interest

RBC Capital analyst Shagun Singh maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Outperform and raises the price target from $515 to $525.

ISRG

RBC Capital Maintains Outperform on Intuitive Surgical, Raises Price Target to $525

RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) with a Outperform and raises the price target from $78 to $80.

GMED

RBC Capital Maintains Outperform on Globus Medical, Raises Price Target to $80

Everybody loves finding a bargain or getting a good deal, and it&#39;s no different when it comes to stocks. One of the most popular technical indicators for helping investors find these is the Relative Strength Index (RSI).&nbsp;
Every stock has one. It works by considering a stock&#39;s recent performance over the past 14 trading days and spitting out a number ranging from 0 to 100. An RSI reading of more than 70 suggests extremely overbought conditions, while a reading below 30 suggests the opposite. The more extreme the reading, the more extreme the suggested condition of the stock.&nbsp;
With the benchmark S&amp;P 500 index back up around all-time highs since the Fed confirmed it was cutting rates, investor sentiment is clearly still bullish. This makes it all the more interesting when you then see a stock selling hard. Any indication that the selling might be verging on overdone or that the bears are running out of steam can mean a quick bounce is in store. With that in mind, here are three stocks with RSI readings that suggest they&#39;re extremely oversold.&nbsp;&nbsp;
<h2>Wall Street Sees Opportunity in Humana&#39;s Oversold Condition</h2>
Humana Inc., the for-profit health insurance company, has been selling off for over two years. Considering the gains the broader market has registered in this timeframe, the Louisville-based company&#39;s underperformance will be a bitter pill.&nbsp;
Its shares were down more than 50% in that timeframe and went back into trading at 2017 levels. Despite beating analyst expectations in its Q2 earnings report over the summer, things have only gotten worse, with yesterday&#39;s negative update on membership numbers the latest headwind to deal with.&nbsp;
At one point yesterday, Humana shares were trading more than 30% off where they closed last week, resulting in an RSI reading of just 15. This is the stock&#39;s lowest reading in 16 years, a fact that hasn&#39;t gone unnoticed by Wall Street. This isn&#39;t a company to be holding for the long run, but the strong buying action all the way into yesterday&#39;s close suggests there&#39;s a fast and hard bounce kicking off that can be capitalized on.&nbsp;
<h2>Elevance Health&#39;s Oversold RSI Suggests Significant Upside Potential</h2>
Though not quite as extreme as Humana&#39;s, Elevance Health, Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/elv#NYSE">ELV</a>)&#39;s RSI reading of 26 does suggest the Indianapolis health insurer is extremely oversold.
Compared to Humana, however, there&#39;s a lot more to like about Elevance for the long term, not least the fact that the company was trading at all-time highs as recently as July.&nbsp;
While its stock has been softening since the first week of September, it gapped down at yesterday&#39;s open. This was almost certainly off the back of Humana&#39;s negative update, and already, it&#39;s being treated as an entry opportunity.&nbsp;
Elevance shares gained into Wednesday&#39;s close and were trading up in Thursday&#39;s pre-market session. Considering how low their RSI still is, however, there&#39;s clearly a ton more room for them to run.&nbsp;
<h2>BioMarin Stock Holds Firm After Sharp Decline, Bulls Eyeing Comeback</h2>
BioMarin Pharmaceutical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmrn#NASDAQ">BMRN</a>) shares of biotech stock have been effectively range-bound since 2016.
Pharmaceutical companies often experience this, as they depend heavily on positive results from drug and treatment trials rather than more standard fundamental performance for their stock&#39;s direction.&nbsp;
September gave a good example of just how exposed these companies can be, even to updates from their peers in this regard. When positive results from an Ascendis Pharma A/S (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asnd#NASDAQ">ASND</a>) trial were announced, they were seen as a threat to BioMarins&#39; ongoing Voxzogo trials.&nbsp;
BioMarin shares lost more than 20% immediately, but the bears could not take it any lower. They have been consolidating since then, which suggests the bulls could soon be back in control. With BioMarin&#39;s RSI still only at 26, though, while its MACD edges closer to a bullish crossover, this one has all the feel of a comeback rally.
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/3-oversold-stocks-with-big-rsi-rebound-potential/">3 Oversold Stocks with Big RSI Rebound Potential</a>&quot; first appeared on MarketBeat.

Biotech

Insurance

General

ASND

BMRN

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

3 Oversold Stocks with Big RSI Rebound Potential

50% Of Treatment Arm Patients Were Immunocompromised And Infected By SARS-CoV-2 Variants From Delta To Omicron BA.5.2; All Treated Patients Returned To Baseline Health Within 14 Days And Showed No Evidence Of Long COVID Or Reinfection At Six-Month Follow-Up; CEO Leads Patient Advocacy At Capitol Hill, Pledging To Utilize Multi-Billion Dollar Assets To Combat Long COVID And Drive Medical Innovation

TVGN

Tevogen Bio Highlights Trial Data Showing No Dose-Limiting Toxicities Or Significant Adverse Events With TVGN 489; Study Endpoints On Safety, Viral Load Reduction, And Anti-COVID-19 Responses Met

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Bonus BioGroup

Bonus BioGroup (BBIXF) Forecast

Bonus BioGroup (OTC:BBIXF) Stock, Quote.Headers.trade-ideas